Cite
APA Citation
Doan, Q., Lalla, D., Yao, B., Danese, M., Barnett, B., & Crown, J. (n.d.). modeling the long-term efficacy of neratinib in the extended adjuvant setting for women with HER2+/HR+ early stage breast cancer (ESBC). Breast, 44, S19–S20. http://access.bl.uk/ark:/81055/vdc_100080181966.0x000028